116 related articles for article (PubMed ID: 1854461)
1. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure.
Raya TE; Fonken SJ; Lee RW; Daugherty S; Goldman S; Wong PC; Timmermans PB; Morkin E
Am J Hypertens; 1991 Apr; 4(4 Pt 2):334S-340S. PubMed ID: 1854461
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats.
Capasso JM; Li P; Meggs LG; Herman MV; Anversa P
J Cardiovasc Pharmacol; 1994 Apr; 23(4):584-93. PubMed ID: 7516008
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.
Smits JF; van Krimpen C; Schoemaker RG; Cleutjens JP; Daemen MJ
J Cardiovasc Pharmacol; 1992; 20(5):772-8. PubMed ID: 1280740
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
5. Survival after myocardial infarction in rats: captopril versus losartan.
Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
[TBL] [Abstract][Full Text] [Related]
6. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
Batin P; Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Jun; 103(2):1585-91. PubMed ID: 1884112
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
Nekooeian AA; Ogilvie RI; Zborowska-Sluis D
Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666
[TBL] [Abstract][Full Text] [Related]
8. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
10. Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure.
Qing G; Garcia R
Am J Physiol; 1992 Sep; 263(3 Pt 2):H833-40. PubMed ID: 1415610
[TBL] [Abstract][Full Text] [Related]
11. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
Fenoy FJ; Scicli G; Carretero O; Roman RJ
Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
[TBL] [Abstract][Full Text] [Related]
12. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
Li T; Zimmerman BG
J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor antagonism in ovine heart failure: acute hemodynamic, hormonal, and renal effects.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H
Am J Physiol; 1992 Jul; 263(1 Pt 2):H250-6. PubMed ID: 1636762
[TBL] [Abstract][Full Text] [Related]
14. [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
Mill JG; Milanez Mda C; Busatto VC; de Moraes AC; Gomes Mda G
Arq Bras Cardiol; 1997 Aug; 69(2):101-10. PubMed ID: 9567332
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150
[TBL] [Abstract][Full Text] [Related]
16. DuP 753 is more effective than captopril on baroreceptor function in high-renin hypertension.
Moreira ED; Ida F; Pires MD; Krieger EM
Hypertension; 1994 Jan; 23(1 Suppl):I64-7. PubMed ID: 8282377
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
[TBL] [Abstract][Full Text] [Related]
18. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats.
Fregly MJ; Rowland NE
Proc Soc Exp Biol Med; 1992 Feb; 199(2):158-64. PubMed ID: 1311103
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacology of DuP 753.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
[TBL] [Abstract][Full Text] [Related]
20. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
